A Randomized Clinical Trial of Repeated Doses of Psilocybin for the Treatment of Obsessive Compulsive Disorder

A landmark clinical trial published in the Journal of Psychopharmacology has provided new evidence that psilocybin, the primary psychoactive compound found in certain species of fungi, may offer a transformative…

Psilocybin slows down human reaction times and impairs executive function during the acute phase of use

The core finding of the meta-analysis is that psilocybin induces a dose-dependent slowing of reaction times across various cognitive domains, while leaving the accuracy of those responses largely intact. These…

An exploration of the relationships between the effects of psilocybin on behavior, 5-HT2A receptor occupancy, and neuroplastic effects in mice.

The therapeutic potential of psychedelic compounds has transitioned from the fringes of counterculture to the forefront of psychiatric research, driven by a global mental health crisis that has left millions…